Turnover: 402 million EUR (2022)
Country: France
Stago was originally a pharmaceutical laboratory created in 1945. The company gradually turned to the In Vitro Diagnostics (IVD) industry and is now the French leader in the field of hemostasis and thrombosis.
In 2017, Hemosonics joined the Stago Group to offer a new approach to delocalized POC biology, distributed in France and Belgium by its new subsidiary Stago BioCare.
Financial Data
DUNS: 305151409
Legal Name: DIAGNOSTICA STAGO
Address: 3 ALL THERESA , 92600 ASNIERES-SUR-SEINE
Number of employees: 1217 (2017)
Capital: 7 509 445
Financial Data:
| Year | Turnover (€) | Net Profit (€) | Fiscal Year End | Fiscal Year Duration |
|---|---|---|---|---|
| 2018 | 320 015 361 EUR | 27 274 759 EUR | 31/12/2018 | 12 |
| 2017 | 347 702 030 EUR | 51 329 455 EUR | 31/12/2017 | 12 |
| 2016 | 332 684 463 EUR | 47 100 436 EUR | 31/12/2016 | 12 |
| 2015 | 326 866 435 EUR | 46 258 384 EUR | 31/12/2015 | 12 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président | Jean-Claude | PIEL | 66 | |
| Directeur général délégué | Patrick | MONNOT | 71 | |
| Directeur général délégué | Antoine | COULOT | 63 |
Studies mentioning this company
The in vitro diagnostics market - France
Other companies mentioned:
- Roche Groupe
- Diagast
- Abbott Groupe
- Danaher
- Thermo Fisher Diagnostics
- Sebia
- BioMerieux Groupe
- Diagnostica Stago
- Biosynex
- Diagnostic Medical System DMS Groupe